Transcription of Michigan Quality Improvement Consortium …
{{id}} {{{paragraph}}}
August 2017 Eligible PopulationKey ComponentsInitial assessmentPatient education and nonpharmacologic interventionsGoals of TherapyPharmacologic interventionsMonitoring and adjustment of therapy [D] Michigan Quality Improvement Consortium GuidelineMedical Management of Adults with HypertensionThe following guideline recommends diagnostic evaluation, education and pharmacologic treatment that support effective patient and Level of EvidenceHypertension, Stage 1: initiate therapy and recheck within two months until goal is , Stage 2: initiate therapy and recheck weekly or more often if indicated. Symptomatic Stage 2 may require hospital monitoring and at each visit.
August 2017 Eligible Population Key Components Initial assessment Patient education and nonpharmacologic interventions Goals of Therapy Pharmacologic
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
KDIGO Clinical, KDIGO Clinical Practice Guideline for Glomerulonephritis, Clinical, Acute Kidney, Acute Kidney Injury, KDIGO, KDIGO Clinical Practice Guideline for, KDIGO Clinical Practice Guideline for Glomerulonephritis KDIGO, KDIGO Clinical Guidelines for Management of, Measures Assessment Tool MAT, Measures Assessment Tool \MAT